Aquinox Pharmaceuticals Current Ratio 2013-2019 | AQXP

Aquinox Pharmaceuticals current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Aquinox Pharmaceuticals Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-03-31 $0.08B $0.00B 20.81
2018-12-31 $0.08B $0.01B 16.68
2018-09-30 $0.09B $0.01B 8.12
2018-06-30 $0.10B $0.01B 7.74
2018-03-31 $0.09B $0.01B 10.07
2017-12-31 $0.11B $0.01B 9.93
2017-09-30 $0.12B $0.01B 17.23
2017-06-30 $0.13B $0.01B 16.26
2017-03-31 $0.12B $0.01B 21.02
2016-12-31 $0.10B $0.01B 10.87
2016-09-30 $0.15B $0.01B 17.12
2016-06-30 $0.07B $0.01B 7.96
2016-03-31 $0.07B $0.01B 12.14
2015-12-31 $0.08B $0.01B 15.61
2015-09-30 $0.12B $0.00B 30.56
2015-06-30 $0.03B $0.00B 7.47
2015-03-31 $0.04B $0.01B 7.04
2014-12-31 $0.04B $0.01B 7.55
2014-09-30 $0.04B $0.01B 8.83
2014-06-30 $0.04B $0.00B 12.77
2014-03-31 $0.06B $0.00B 45.45
2013-12-31 $0.02B $0.00B 5.84
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 5.42
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.055B $0.025B
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company discovers and develops oral drug candidates to treat inflammation and cancer. Aquinox Pharmaceuticals, Inc. is headquartered in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $39.546B 7.20
Mylan (MYL) United Kingdom $9.149B 4.00
Teva Pharmaceutical Industries (TEVA) Israel $8.501B 3.33
Bausch Health Cos (BHC) Canada $7.896B 5.39
Dr Reddy's Laboratories (RDY) India $6.152B 23.01
Supernus Pharmaceuticals (SUPN) United States $1.640B 16.39
Voyager Therapeutics (VYGR) United States $1.027B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.968B 54.10
Homology Medicines (FIXX) United States $0.877B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.784B 1.17
Akorn (AKRX) United States $0.564B 0.00
CymaBay Therapeutics (CBAY) United States $0.487B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.394B 0.00
Assembly Biosciences (ASMB) United States $0.365B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.291B 0.00
Sol-Gel Technologies (SLGL) Israel $0.163B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.137B 0.00
Acasti Pharma (ACST) Canada $0.073B 0.00
Agile Therapeutics (AGRX) United States $0.060B 0.00
Teligent (TLGT) United States $0.026B 0.00
Evoke Pharma (EVOK) United States $0.014B 0.00
China Pharma Holdings (CPHI) China $0.014B 0.00
Aevi Genomic Medicine (GNMX) United States $0.012B 0.00